Patents Assigned to Puratos NV/SA
  • Publication number: 20210321631
    Abstract: The present invention relates to a polypeptide having lipolytic enzyme activity, selected from the group consisting of: (a) a polypeptide having at least 65% sequence identity to amino acids 21 to 309 of SEQ ID NO: 1; (b) a polypeptide encoded by a polynucleotide that hybridizes under medium stringency conditions with the polypeptide coding sequence of SEQ ID NO: 2; (c) a polypeptide encoded by a polynucleotide having at least 65% sequence identity to the polypeptide coding sequence of SEQ ID NO: 2; and (d) a fragment of the polypeptide of (a), (b) or (c) that has lipolytic enzyme activity.
    Type: Application
    Filed: June 3, 2021
    Publication date: October 21, 2021
    Applicants: Novozymes A/S, Puratos NV/SA
    Inventors: Henrik Oestdal, Sara Maria Landvik, Robert Piotr Olinski, Evelien Agache, Bruno Van Winckel, Filip Arnaut
  • Publication number: 20210219559
    Abstract: The invention provides a method for preparing a solid enzymatic unit-dose article for use in baking, which is capable of disintegrating/dissolving during preparation of a dough or a batter.
    Type: Application
    Filed: June 4, 2019
    Publication date: July 22, 2021
    Applicants: Novozymes A/S, Puratos NV/SA
    Inventors: Ole Simonsen, Katrine Larson, Kjersti Slot Hansen, Karina Lundberg, Tim Van Caelenberg, Isabel Vanhuele
  • Patent number: 11051520
    Abstract: A polypeptide having lipolytic enzyme activity, selected from the group consisting of: (a) a polypeptide having at least 65% sequence identity to amino acids 21 to 309 of SEQ ID NO: 1; (b) a polypeptide encoded by a polynucleotide that hybridizes under medium stringency conditions with the polypeptide coding sequence of SEQ ID NO: 2; (c) a polypeptide encoded by a polynucleotide having at least 65% sequence identity to the polypeptide coding sequence of SEQ ID NO: 2; and (d) a fragment of the polypeptide of (a), (b) or (c) that has lipolytic enzyme activity.
    Type: Grant
    Filed: February 19, 2018
    Date of Patent: July 6, 2021
    Assignees: Novozymes A/S, Puratos NV/SA
    Inventors: Henrik Oestdal, Sara Maria Landvik, Robert Piotr Olinski, Evelien Agache, Bruno Van Winckel, Filip Arnaut
  • Publication number: 20190364912
    Abstract: A polypeptide having lipolytic enzyme activity, selected from the group consisting of: (a) a polypeptide having at least 65% sequence identity to amino acids 21 to 309 of SEQ ID NO: 1; (b) a polypeptide encoded by a polynucleotide that hybridizes under medium stringency conditions with the polypeptide coding sequence of SEQ ID NO: 2; (c) a polypeptide encoded by a polynucleotide having at least 65% sequence identity to the polypeptide coding sequence of SEQ ID NO: 2; and (d) a fragment of the polypeptide of (a), (b) or (c) that has lipolytic enzyme activity.
    Type: Application
    Filed: February 19, 2018
    Publication date: December 5, 2019
    Applicants: Novozymes A/S, Puratos NV/SA
    Inventors: Henrik Oestdal, Sara Maria Landvik, Robert Piotr Olinski, Evelien Agache, Bruno Van Winckel, Filip Arnaut